Israel China Biotechnology (ICB) Ltd (ICB) — Cash Flow Quality Index

Latest as of June 2021: -42.34x

Israel China Biotechnology (ICB) Ltd (ICB) has a Cash Flow Quality Index of -42.34x as of June 2021. Operating cash flow of ILA-1.06 Million is below net income of ILA25.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore ICB cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-42.34x

Operating CF / Net Income

Operating Cash Flow

ILA-1.06 Million

ILA

Net Income

ILA25.00K

ILA

Data as of

Jun 2021

Most recent filing

Annual Cash Flow Quality Index for Israel China Biotechnology (ICB) Ltd (None–None)

Year-by-year earnings quality comparison for Israel China Biotechnology (ICB) Ltd.

Year	Quality Index	Operating CF (ILA)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.